School of Medicine
Showing 201-210 of 265 Results
-
Joshua Aaron Villarreal
Affiliate, Department Funds
Fellow in Graduate Medical EducationBioDr. Villarreal is a current clinical informatics fellow at Stanford Medicine and first surgical resident to enter the program. He began general surgery training at Stanford in 2020. Dr. Villarreal is a Texas native and hometown is in McAllen TX. He completed medical school at Baylor College of Medicine in 2020 and undergraduate studies in Human Biology at the University of Texas.
During residency, Dr. Villarreal has published numerous articles in a wide range of surgical fields including: pediatric surgery, liver transplantation, trauma critical care and surgical data science. He currently holds the role as president of the resident led surgical research group Surgeon’s Writing About Trauma (SWAT) and mentors medical students and undergrads in conducting surgical related clinical research. He is a member of the Artificial Intelligence in Surgery research group at Stanford focused on leveraging methods in machine learning in the care of transplant patients.
His long-term goals are to apply clinical informatics frameworks to optimize surgical care workflows, enhance intraoperative decision making, and increase accessibility of outpatient surgical services to lower income patients. -
Sylvia Elizabeth Villarreal Navarro
Postdoctoral Scholar, Ophthalmology
BioPhysician-scientist passionate about identifying biomarkers in Multiple Sclerosis, Neuromyelitis Optica (NMO), and MOG antibody-associated diseases through noninvasive imaging of the retina (the most accessible part of the central nervous system). Co-founder of the podcast Book Meets Author, where I explore the minds behind my favorite books. In my free time, I enjoy playing tennis, dancing (Bachata, Salsa, and Tango), and singing karaoke.
-
Anne Villeneuve
Berthold and Belle N. Guggenhime Professor and Professor of Developmental Biology and of Genetics
Current Research and Scholarly InterestsMechanisms underlying homologous chromosome pairing, DNA recombination and chromosome remodeling during meiosis, using the nematode Caenorhabditis elegans as an experimental system. High-resolution 3-D imaging of dynamic reorganization of chromosome architecture. Role of protease inhibitors in regulating sperm activation.
-
Dr. Janaki Manoja Vinnakota
Affiliate, Medicine - Med/Oncology
Visiting Postdoctoral Scholar, Medicine - Med/OncologyBioJanaki Manoja Vinnakota PhD is a Junior Group Leader under Prof. Dr. Robert Zeiser in the Department of Hematology, Oncology, and Stem Cell Transplantation at the University Medical Center Freiburg, Germany. She is a visiting post-doctoral scholar under Prof. Dr. Dean Felsher, Division of Oncology, Stanford school of Medicine. Dr. Vinnakota’s research provided insights into understanding the pathomechanisms associated with central nervous system (CNS) related toxicities such as graft versus host diseases (CNS-GVHD), neurological immune related adverse events (nirAEs) and immune cell associated neurotoxicity syndrome (ICANS) and has most importantly unveiled therapeutic targets with high translational value. She identified the critical role of microglia/myeloid cells in mediating the neurotoxicity and cognitive impairment post diverse cancer immunotherapies. Her work on microglial Syk activation post immune checkpoint inhibition led to a translational application of the most promising and clinically available Syk inhibitor to target CNS irAEs. Dr. Vinnakota was awarded the highly competitive Hans A Krebs Medical Scientist grant, Germany to develop novel therapies that target CAR T cell associated toxicities.
Dr. Vinnakota holds a bachelor's and master's degree in engineering with a focus on biotechnology from IIT Madras, India. Her strong foundation in basic biology has enabled her to investigate projects with significant translational potential. For her Ph.D., Dr. Vinnakota studied the mechanisms of neurotoxicity following allogeneic stem cell transplantation and CAR T cell therapy. During her postdoctoral research, she expanded her expertise to explore neurotoxicity’s associated with immune checkpoint inhibition (anti-PD-1), the gut-microbiome axis in CNS-GVHD, and novel Kinase inhibition strategies to address GVHD.
Dr. Vinnakota was also honored with the prestigious Jan van Rood award from the EBMT society for her work on Targeting ICANS after CD19 CAR T cell therapy and she received the Prize for Innovative Research Approaches in Oncology by the Mertesmann Foundation, Germany for her work on the mechanisms of ICANS after CD19 CAR T cell therapy. Her contributions to immuno-oncology have been published in leading journals such as Nature Cancer, Science Translational Medicine, Journal of Clinical Investigation, and Nature Communications.
